Mednax Inc Stock Performance
| MD Stock | USD 21.71 0.19 0.88% |
The company secures a Beta (Market Risk) of 0.89, which conveys possible diversification benefits within a given portfolio. Mednax returns are very sensitive to returns on the market. As the market goes up or down, Mednax is expected to follow. At this point, Mednax Inc has a negative expected return of -0.0887%. Please make sure to verify Mednax's potential upside, and the relationship between the jensen alpha and daily balance of power , to decide if Mednax Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Mednax Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Mednax is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Actual Historical Performance (%)
One Day Return 2.14 | Five Day Return 2.04 | Year To Date Return 1.08 | Ten Year Return (66.88) | All Time Return 302.71 |
Last Split Factor 2:1 | Last Split Date 2013-12-20 |
1 | Does Pediatrix Medical Groups Upgraded Profit Outlook Signal a Shift in Its Investment Narrative for MD | 11/19/2025 |
2 | SG Americas Securities LLC Boosts Stock Position in Pediatrix Medical Group, Inc. MD | 11/26/2025 |
3 | Comparing Pediatrix Medical Group and PACS Group | 12/11/2025 |
4 | Pediatrix Medical Group, Inc. Receives Consensus Recommendation of Moderate Buy from Analysts | 12/17/2025 |
5 | Is Pediatrix Medical Group Pricing Look Compelling After Recent Share Price Pullback | 01/28/2026 |
6 | 1 Stock Under 50 with Competitive Advantages and 2 We Brush Off | 02/11/2026 |
| Begin Period Cash Flow | 73.3 M | |
| Total Cashflows From Investing Activities | -35.4 M |
Mednax Relative Risk vs. Return Landscape
If you would invest 2,293 in Mednax Inc on November 19, 2025 and sell it today you would lose (143.50) from holding Mednax Inc or give up 6.26% of portfolio value over 90 days. Mednax Inc is generating negative expected returns and assumes 1.8662% volatility on return distribution over the 90 days horizon. Put differently, 16% of stocks are less risky than Mednax on the basis of their historical return distribution, and some 99% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Mednax Target Price Odds to finish over Current Price
The tendency of Mednax Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 21.71 | 90 days | 21.71 | about 67.03 |
Based on a normal probability distribution, the odds of Mednax to move above the current price in 90 days from now is about 67.03 (This Mednax Inc probability density function shows the probability of Mednax Stock to fall within a particular range of prices over 90 days) .
Mednax Price Density |
| Price |
Predictive Modules for Mednax
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mednax Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mednax's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Mednax Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Mednax is not an exception. The market had few large corrections towards the Mednax's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Mednax Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Mednax within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.12 | |
β | Beta against Dow Jones | 0.89 | |
σ | Overall volatility | 0.93 | |
Ir | Information ratio | -0.07 |
Mednax Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mednax for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mednax Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Mednax Inc generated a negative expected return over the last 90 days | |
| The company generated the yearly revenue of 2.01 B. Annual Net Loss to common stockholders was (99.07 M) with gross profit of 496.24 M. | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: 1 Stock Under 50 with Competitive Advantages and 2 We Brush Off |
Mednax Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Mednax Stock often depends not only on the future outlook of the current and potential Mednax's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mednax's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 83.3 M | |
| Cash And Short Term Investments | 348.5 M |
Mednax Fundamentals Growth
Mednax Stock prices reflect investors' perceptions of the future prospects and financial health of Mednax, and Mednax fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mednax Stock performance.
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0686 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 2.03 B | ||||
| Shares Outstanding | 85.88 M | ||||
| Price To Earning | 89.39 X | ||||
| Price To Book | 2.07 X | ||||
| Price To Sales | 0.97 X | ||||
| Revenue | 2.01 B | ||||
| Gross Profit | 496.24 M | ||||
| EBITDA | (28.37 M) | ||||
| Net Income | (99.07 M) | ||||
| Cash And Equivalents | 229.94 M | ||||
| Cash Per Share | 1.29 X | ||||
| Total Debt | 662.31 M | ||||
| Debt To Equity | 1.03 % | ||||
| Current Ratio | 1.39 X | ||||
| Book Value Per Share | 10.59 X | ||||
| Cash Flow From Operations | 206.57 M | ||||
| Earnings Per Share | 1.91 X | ||||
| Market Capitalization | 1.87 B | ||||
| Total Asset | 2.15 B | ||||
| Retained Earnings | (248.54 M) | ||||
| Working Capital | 205.5 M | ||||
| Current Asset | 527.77 M | ||||
| Current Liabilities | 428.77 M | ||||
About Mednax Performance
By analyzing Mednax's fundamental ratios, stakeholders can gain valuable insights into Mednax's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mednax has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mednax has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 46.47 | 44.15 | |
| Return On Tangible Assets | (0.13) | (0.12) | |
| Return On Capital Employed | (0.05) | (0.04) | |
| Return On Assets | (0.05) | (0.05) | |
| Return On Equity | (0.15) | (0.14) |
Things to note about Mednax Inc performance evaluation
Checking the ongoing alerts about Mednax for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mednax Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mednax Inc generated a negative expected return over the last 90 days | |
| The company generated the yearly revenue of 2.01 B. Annual Net Loss to common stockholders was (99.07 M) with gross profit of 496.24 M. | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: 1 Stock Under 50 with Competitive Advantages and 2 We Brush Off |
- Analyzing Mednax's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mednax's stock is overvalued or undervalued compared to its peers.
- Examining Mednax's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mednax's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mednax's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mednax's stock. These opinions can provide insight into Mednax's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Mednax Stock analysis
When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |